DNA breaks and repair in lymphocytes as a diagnostic marker in patients with gastric cancer

Authors

  • A.B. Tulyayeva ЗКМУ имени Марата Оспанова
  • N.M. Kereeva
  • D.A. Zholmukhamedova
  • G.A. Batyrova
  • G.A. Zhurabekova
  • N.M. Imanbayev
  • P.A. Aitmagambet
  • A.K. Koishybaev
  • E.M. Iztleuov
  • M.A. Aitmagambetova

DOI:

https://doi.org/10.52532/2521-6414-2024-1-71-35-39

Keywords:

Double-strand DNA breaks, γ-H2AX, 53BP1, gastric cancer

Abstract

Relevance: Timely detection of foci of double-strand DNA breaks with subsequent initiation of the repair mechanism plays a crucial role in the overall response to DNA damage. Untimely resolution of double-strand DNA breaks and disruptions in the repair pathway constitute a fundamental mechanism in cancer development and progression. A search for biomarkers is needed to identify foci of double-strand DNA breaks and achieve a better outcome of targeted therapy.

The study aimed to identify comparative differences in double-strand breaks and DNA repair activity in γ-H2AX and 53BP1 parameters in conditionally healthy individuals and patients with gastric cancer.

Methods: Analysis of focal points of γ-H2AX, 53BP1 with lymphocyte parameters using the automated AKLIDES® system in gastric cancer patients (n=30) and conditionally healthy individuals (n=30).

Results: Statistically significant differences were found between conditionally healthy individuals and patients with gastric cancer in γ-H2AX parameters: ‘Total number of breaks’ (p=0.001), ‘Number of nuclei with break foci’ (p=0.015), ‘Average number of breaks per cell’ (p=0.016), ‘Mean value of all break foci per cell’ (p=0.001), and in 53BP1 parameters: ‘Number of nuclei with repair foci’ (p=0.001), ‘Mean intensity of repair fluorescence in arbitrary units’ (p=0.001), ‘Mean number of repairs per cell’ (p=0.001), and ‘Damaged cells with low fluorescence intensity’ (p=0.019).

Conclusion: Biomarkers of double-strand DNA breaks with repair activity (γ-H2AX, 53BP1) have clinical significance, contributing to the development of targeted medicine in oncology.

Downloads

Published

06.09.2024

How to Cite

Tulyayeva, A. ., Kereeva, N., Zholmukhamedova, D., Batyrova, G., Zhurabekova, G., Imanbayev, N., Aitmagambet, P., Koishybaev, A., Iztleuov, E., & Aitmagambetova, M. (2024). DNA breaks and repair in lymphocytes as a diagnostic marker in patients with gastric cancer. Oncology and Radiology of Kazakhstan, 1(71), 35-39. https://doi.org/10.52532/2521-6414-2024-1-71-35-39